Skip to main content
Signal8

Ingredion Inc (INGR) Form 8-K — Jun 25, 2026

$INGRForm 8-KItems 1.01, 2.03, 9.01Filed Jun 25, 2026, 4:18 PM ET0001628280-26-045521Original filing

Ingredion Incorporated entered into a Delayed Draw Term Loan Agreement totaling $1.475 billion to finance its cash acquisition of Tate & Lyle PLC. The facility consists of a $500 million Tranche A-1 with a three-year maturity and a $975 million Tranche B-1 with a five-year maturity. This financing replaces a portion of the company's previously established $4.225 billion bridge loan facility, specifically the $1.475 billion Tranche A commitment. The proceeds will be used to pay the cash consideration for the acquisition, refinance certain outstanding indebtedness of Tate & Lyle, and cover related fees and expenses.

Key figures

Debt Amount
1475000000
Tranche a1 amount
500000000
Tranche b1 amount
975000000
Max leverage ratio
3.5 to 1.0
Tranche a1 maturity
3 years
Tranche b1 maturity
5 years
Min interest coverage ratio
3.5 to 1.0

Price after filing

1 day: 0.0%7 days: +0.8%30 days: +3.5%

Close on the filing date to close N calendar days later (from $96.82). Historical, not a forecast.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.